TrialAnnals of oncology : official journal of the European Society for Medical Oncology2014

Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA.

S M Swain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.